Specifically, we reported that, beginning at a threshold of about 10 Gy, SDRT engages acid sphingomyelinase (ASMase)/ceramide signaling in tumor microvasculature (3), resulting in an imbalance between the dilatory effects of nitric oxide and the constrictive effects of endothelin (8–10). This evidence concerns the gene SMPD1 and neoplasm.